Robert et al[11] considered that the increased PSA level, before radiotherapy, may be a prognostic indicator of radiotherapy and antiandrogen therapy for prostate cancer, and the antiandrogen treatment of patients receiving radiotherapy is related to the improvement of prognosis. This evidence concerns the gene KLK3 and Familial prostate cancer.